New Key Statistics Module, Z-Score and F-Score
NAS:APLS Key Ratios
| Market Cap $ M | 4,764.81 |
| Enterprise Value $ M | 4,548.02 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 17.85 |
| Price/Sales | 9.08 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 524.00 |
| EPS (TTM) $ | -3.46 |
| Beneish M-Score | 2.79 |
| 10-y EBITDA Growth Rate % | -33.90 |
| 5-y EBITDA Growth Rate % | -13.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -11.78 |
| EV-to-EBITDA | -11.83 |
| PEG | -- |
| Shares Outstanding M | 121.37 |
| Net Margin (%) | -79.62 |
| Operating Margin % | -77.11 |
| Pre-tax Margin (%) | -79.24 |
| Quick Ratio | 3.02 |
| Current Ratio | 3.77 |
| ROA % (ttm) | -48.15 |
| ROE % (ttm) | -143.79 |
| ROIC % (ttm) | -174.18 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.13 |
APLS Number of Guru Trades
APLS Volume of Guru Trades
Gurus Latest Trades with NAS:APLS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:APLS is held by these investors
Total 4
Apellis Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:APLS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers